# ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial

> **NCT04084249** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Claus Lindbjerg Andersen** · enrollment: 359 (actual)

## Conditions studied

- Colorectal Cancer
- Colo-rectal Cancer
- ctDNA
- Gastro-Intestinal Disorder
- Colorectal Neoplasms
- Gastrointestinal Cancer
- Gastrointestinal Neoplasms
- Digestive System Disease
- Digestive System Neoplasm
- Colonic Diseases
- Colonic Neoplasms
- Colonic Cancer
- Rectal Diseases
- Rectal Neoplasms
- Rectal Cancer

## Interventions

- **DIAGNOSTIC_TEST:** ctDNA-analysis
- **OTHER:** Intensified Follow-up Schedule

## Key facts

- **NCT ID:** NCT04084249
- **Lead sponsor:** Claus Lindbjerg Andersen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-01-01
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-06-30
- **Target enrollment:** 359 (ACTUAL)
- **Last updated:** 2026-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04084249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04084249, "ctDNA-guided Surveillance for Stage III CRC, a Randomized Intervention Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04084249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*